argenx Completes Forte Biosciences Acquisition for FB102
Amsterdam, the Netherlands – August 27, 2026 argenx announced the successful completion of its acquisition of Forte Biosciences, Inc.,...
acquisition
Advertisement
Teledyne to Acquire Varex Imaging in $1.1 Billion Deal Today
Thousand Oaks, California & Salt Lake City, Utah, August, 10, 2026 Teledyne Technologies Incorporated and Varex Imaging Corporation have...
Harrow Acquires TYRVAYA Global Rights, Expands Dry Eye Portfolio
NASHVILLE, Tenn., August 6, 2026 Harrow Inc. announced it has entered into a definitive agreement to acquire the global...
Moderna Begins Phase 1 Trial for Ebola mRNA Vaccine
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
SystImmune Launches Global Phase 3 Trial of BL-M14D1
Redmond, Washington, August 5, 2026 SystImmune, Inc., a clinical-stage biotechnology company and subsidiary of Biokin, has announced that the...
Advertisements
Integer to Be Acquired by KKR in $5.7 Billion Deal
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
Curium to Merge with Lantheus in $8B Radiopharma Deal
Boston & Bedford, Massachusetts, August 3, 2026 Curium and Lantheus Holdings, Inc. have entered into a definitive merger agreement...
Haemonetics Study Validates VASCADE MVP XL Performance
Boston, Massachusetts, August 3, 2026 Haemonetics Corporation has announced the publication of a major real-world clinical study providing additional...
Ceribell Secures CMS NTAP for Delirium Monitor System
SUNNYVALE, Calif., Aug. 3, 2026 Ceribell, Inc. has secured a significant reimbursement milestone after the U.S. Centers for Medicare...
Supernus Pharmaceuticals and Indivior to Merge in $2.2 Billion CNS Biopharma Deal
ROCKVILLE, Md. & RICHMOND, Va., Aug. 3, 2026 Supernus Pharmaceuticals and Indivior Pharmaceuticals announced they have entered into a...
Advertisement
